Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Pharma
To boost production of T1D candidates, Vertex jumps to TreeFrog
Helping Vertex develop three pipeline candidates in Type 1 diabetes will be French cell therapy developer and manufacturer TreeFrog Therapeutics.
Kevin Dunleavy
Apr 24, 2024 7:25am
Orphan drug market to reach $270B by 2028: Evaluate
Apr 24, 2024 12:01am
Reshma Kewalramani joins exclusive club, topping $20M in pay
Apr 8, 2024 8:26am
NICE rejects Vertex, CRISPR's Casgevy, asks for more data
Mar 14, 2024 11:24am
Michigan Medicaid signs deal with bluebird for SCD gene therapy
Mar 11, 2024 11:00am
Vertex's sales of Trikafta hit $8.9B thanks to label expansion
Feb 6, 2024 12:39pm